359 related articles for article (PubMed ID: 28394331)
1. Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance.
Daley D; Mani VR; Mohan N; Akkad N; Ochi A; Heindel DW; Lee KB; Zambirinis CP; Pandian GSB; Savadkar S; Torres-Hernandez A; Nayak S; Wang D; Hundeyin M; Diskin B; Aykut B; Werba G; Barilla RM; Rodriguez R; Chang S; Gardner L; Mahal LK; Ueberheide B; Miller G
Nat Med; 2017 May; 23(5):556-567. PubMed ID: 28394331
[TBL] [Abstract][Full Text] [Related]
2. The necrosome promotes pancreatic oncogenesis via CXCL1 and Mincle-induced immune suppression.
Seifert L; Werba G; Tiwari S; Giao Ly NN; Alothman S; Alqunaibit D; Avanzi A; Barilla R; Daley D; Greco SH; Torres-Hernandez A; Pergamo M; Ochi A; Zambirinis CP; Pansari M; Rendon M; Tippens D; Hundeyin M; Mani VR; Hajdu C; Engle D; Miller G
Nature; 2016 Apr; 532(7598):245-9. PubMed ID: 27049944
[TBL] [Abstract][Full Text] [Related]
3. Tumor Cell-Derived IL1β Promotes Desmoplasia and Immune Suppression in Pancreatic Cancer.
Das S; Shapiro B; Vucic EA; Vogt S; Bar-Sagi D
Cancer Res; 2020 Mar; 80(5):1088-1101. PubMed ID: 31915130
[TBL] [Abstract][Full Text] [Related]
4. The receptor for advanced glycation end products promotes pancreatic carcinogenesis and accumulation of myeloid-derived suppressor cells.
Vernon PJ; Loux TJ; Schapiro NE; Kang R; Muthuswamy R; Kalinski P; Tang D; Lotze MT; Zeh HJ
J Immunol; 2013 Feb; 190(3):1372-9. PubMed ID: 23269246
[TBL] [Abstract][Full Text] [Related]
5. Targeting galectin-1 inhibits pancreatic cancer progression by modulating tumor-stroma crosstalk.
Orozco CA; Martinez-Bosch N; Guerrero PE; Vinaixa J; Dalotto-Moreno T; Iglesias M; Moreno M; Djurec M; Poirier F; Gabius HJ; Fernandez-Zapico ME; Hwang RF; Guerra C; Rabinovich GA; Navarro P
Proc Natl Acad Sci U S A; 2018 Apr; 115(16):E3769-E3778. PubMed ID: 29615514
[TBL] [Abstract][Full Text] [Related]
6. RIP1 Kinase Drives Macrophage-Mediated Adaptive Immune Tolerance in Pancreatic Cancer.
Wang W; Marinis JM; Beal AM; Savadkar S; Wu Y; Khan M; Taunk PS; Wu N; Su W; Wu J; Ahsan A; Kurz E; Chen T; Yaboh I; Li F; Gutierrez J; Diskin B; Hundeyin M; Reilly M; Lich JD; Harris PA; Mahajan MK; Thorpe JH; Nassau P; Mosley JE; Leinwand J; Kochen Rossi JA; Mishra A; Aykut B; Glacken M; Ochi A; Verma N; Kim JI; Vasudevaraja V; Adeegbe D; Almonte C; Bagdatlioglu E; Cohen DJ; Wong KK; Bertin J; Miller G
Cancer Cell; 2018 Nov; 34(5):757-774.e7. PubMed ID: 30423296
[TBL] [Abstract][Full Text] [Related]
7. NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma.
Daley D; Mani VR; Mohan N; Akkad N; Pandian GSDB; Savadkar S; Lee KB; Torres-Hernandez A; Aykut B; Diskin B; Wang W; Farooq MS; Mahmud AI; Werba G; Morales EJ; Lall S; Wadowski BJ; Rubin AG; Berman ME; Narayanan R; Hundeyin M; Miller G
J Exp Med; 2017 Jun; 214(6):1711-1724. PubMed ID: 28442553
[TBL] [Abstract][Full Text] [Related]
8. Activation of NF-κB and respiratory burst following Aspergillus fumigatus stimulation of macrophages.
Sun H; Xu XY; Tian XL; Shao HT; Wu XD; Wang Q; Su X; Shi Y
Immunobiology; 2014 Jan; 219(1):25-36. PubMed ID: 23886693
[TBL] [Abstract][Full Text] [Related]
9. Macrophage PI3Kγ Drives Pancreatic Ductal Adenocarcinoma Progression.
Kaneda MM; Cappello P; Nguyen AV; Ralainirina N; Hardamon CR; Foubert P; Schmid MC; Sun P; Mose E; Bouvet M; Lowy AM; Valasek MA; Sasik R; Novelli F; Hirsch E; Varner JA
Cancer Discov; 2016 Aug; 6(8):870-85. PubMed ID: 27179037
[TBL] [Abstract][Full Text] [Related]
10. Dectin-1 limits autoimmune neuroinflammation and promotes myeloid cell-astrocyte crosstalk via Card9-independent expression of Oncostatin M.
Deerhake ME; Danzaki K; Inoue M; Cardakli ED; Nonaka T; Aggarwal N; Barclay WE; Ji RR; Shinohara ML
Immunity; 2021 Mar; 54(3):484-498.e8. PubMed ID: 33581044
[TBL] [Abstract][Full Text] [Related]
11. Activating Immune Recognition in Pancreatic Ductal Adenocarcinoma via Autophagy Inhibition, MEK Blockade, and CD40 Agonism.
Jiang H; Courau T; Borison J; Ritchie AJ; Mayer AT; Krummel MF; Collisson EA
Gastroenterology; 2022 Feb; 162(2):590-603.e14. PubMed ID: 34627860
[TBL] [Abstract][Full Text] [Related]
12. Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection.
Robinson MJ; Osorio F; Rosas M; Freitas RP; Schweighoffer E; Gross O; Verbeek JS; Ruland J; Tybulewicz V; Brown GD; Moita LF; Taylor PR; Reis e Sousa C
J Exp Med; 2009 Aug; 206(9):2037-51. PubMed ID: 19703985
[TBL] [Abstract][Full Text] [Related]
13. Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer.
Feig C; Jones JO; Kraman M; Wells RJ; Deonarine A; Chan DS; Connell CM; Roberts EW; Zhao Q; Caballero OL; Teichmann SA; Janowitz T; Jodrell DI; Tuveson DA; Fearon DT
Proc Natl Acad Sci U S A; 2013 Dec; 110(50):20212-7. PubMed ID: 24277834
[TBL] [Abstract][Full Text] [Related]
14. Detection of pancreatic ductal adenocarcinoma with galectin-9 serum levels.
Seifert AM; Reiche C; Heiduk M; Tannert A; Meinecke AC; Baier S; von Renesse J; Kahlert C; Distler M; Welsch T; Reissfelder C; Aust DE; Miller G; Weitz J; Seifert L
Oncogene; 2020 Apr; 39(15):3102-3113. PubMed ID: 32055023
[TBL] [Abstract][Full Text] [Related]
15. Dectin-1/Syk signaling is involved in Lactobacillus casei cell wall extract-induced mouse model of Kawasaki disease.
Lin IC; Suen JL; Huang SK; Huang SC; Huang HC; Kuo HC; Wei CC; Wang FS; Yu HR; Yang KD
Immunobiology; 2013 Feb; 218(2):201-12. PubMed ID: 22633994
[TBL] [Abstract][Full Text] [Related]
16. Dectin-2 Is a C-Type Lectin Receptor that Recognizes Pneumocystis and Participates in Innate Immune Responses.
Kottom TJ; Hebrink DM; Jenson PE; Marsolek PL; Wüthrich M; Wang H; Klein B; Yamasaki S; Limper AH
Am J Respir Cell Mol Biol; 2018 Feb; 58(2):232-240. PubMed ID: 28886250
[TBL] [Abstract][Full Text] [Related]
17. BCAT2-mediated BCAA catabolism is critical for development of pancreatic ductal adenocarcinoma.
Li JT; Yin M; Wang D; Wang J; Lei MZ; Zhang Y; Liu Y; Zhang L; Zou SW; Hu LP; Zhang ZG; Wang YP; Wen WY; Lu HJ; Chen ZJ; Su D; Lei QY
Nat Cell Biol; 2020 Feb; 22(2):167-174. PubMed ID: 32029896
[TBL] [Abstract][Full Text] [Related]
18. Cadherin 11 Promotes Immunosuppression and Extracellular Matrix Deposition to Support Growth of Pancreatic Tumors and Resistance to Gemcitabine in Mice.
Peran I; Dakshanamurthy S; McCoy MD; Mavropoulos A; Allo B; Sebastian A; Hum NR; Sprague SC; Martin KA; Pishvaian MJ; Vietsch EE; Wellstein A; Atkins MB; Weiner LM; Quong AA; Loots GG; Yoo SS; Assefnia S; Byers SW
Gastroenterology; 2021 Mar; 160(4):1359-1372.e13. PubMed ID: 33307028
[TBL] [Abstract][Full Text] [Related]
19. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
[TBL] [Abstract][Full Text] [Related]
20. Specialized dendritic cells induce tumor-promoting IL-10
Barilla RM; Diskin B; Caso RC; Lee KB; Mohan N; Buttar C; Adam S; Sekendiz Z; Wang J; Salas RD; Cassini MF; Karlen J; Sundberg B; Akbar H; Levchenko D; Gakhal I; Gutierrez J; Wang W; Hundeyin M; Torres-Hernandez A; Leinwand J; Kurz E; Rossi JAK; Mishra A; Liria M; Sanchez G; Panta J; Loke P; Aykut B; Miller G
Nat Commun; 2019 Mar; 10(1):1424. PubMed ID: 30926808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
